You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Harvard Business School
Merck
McKesson
AstraZeneca
Colorcon

Last Updated: August 9, 2020

DrugPatentWatch Database Preview

METHYLPREDNISOLONE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Methylprednisolone, and when can generic versions of Methylprednisolone launch?

Methylprednisolone is a drug marketed by Elkins Sinn, Organon Usa Inc, Duramed Pharms Barr, Heather, Invatech, Jubilant Cadista, Lupin Ltd, Novast Labs, Par Pharm, Sandoz, Sungen Pharma, Tianjin Tianyao, Vintage Pharms, Watson Labs, Zydus Pharms, Akorn, Amneal, Sagent Pharms Inc, Sandoz Inc, Teva Pharms Usa, Abraxis Pharm, Aurobindo Pharma Ltd, Bedford Labs, Fresenius Kabi Usa, Hikma, Intl Medication, and Teva Parenteral. and is included in sixty-two NDAs.

The generic ingredient in METHYLPREDNISOLONE is methylprednisolone acetate. There are forty drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the methylprednisolone acetate profile page.

US ANDA Litigation and Generic Entry Outlook for Methylprednisolone

A generic version of METHYLPREDNISOLONE was approved as methylprednisolone acetate by TEVA PHARMS USA on February 23rd, 2005.

  Start Trial

Drug patent expirations by year for METHYLPREDNISOLONE
Drug Prices for METHYLPREDNISOLONE

See drug prices for METHYLPREDNISOLONE

Drug Sales Revenue Trends for METHYLPREDNISOLONE

See drug sales revenues for METHYLPREDNISOLONE

Recent Clinical Trials for METHYLPREDNISOLONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Rabin Medical CenterPhase 2
Al-Azhar UniversityPhase 4
Damietta UniversityPhase 2

See all METHYLPREDNISOLONE clinical trials

Pharmacology for METHYLPREDNISOLONE
Medical Subject Heading (MeSH) Categories for METHYLPREDNISOLONE

US Patents and Regulatory Information for METHYLPREDNISOLONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bedford Labs METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040662-001 Feb 21, 2007 DISCN No No   Start Trial   Start Trial   Start Trial
Sandoz Inc METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 040794-001 Mar 5, 2009 AB RX No No   Start Trial   Start Trial   Start Trial
Zydus Pharms METHYLPREDNISOLONE methylprednisolone TABLET;ORAL 206751-004 Apr 23, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
Sagent Pharms Inc METHYLPREDNISOLONE SODIUM SUCCINATE methylprednisolone sodium succinate INJECTABLE;INJECTION 040888-004 Jul 18, 2011 AP RX No No   Start Trial   Start Trial   Start Trial
Watson Labs METHYLPREDNISOLONE ACETATE methylprednisolone acetate INJECTABLE;INJECTION 087248-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Baxter
Moodys
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.